Search Results - "Yip, Terry C.‐F."

Refine Results
  1. 1

    Letter: is tenofovir superior to entecavir for hepatocellular carcinoma prevention in chronic hepatitis B? Authors’ reply by Yip, Terry C.‐F., Wong, Grace L.‐H.

    Published in Alimentary pharmacology & therapeutics (01-01-2020)
    “…LINKED CONTENTThis article is linked to Brancaccio et al and Yuan et al papers. To view these articles, visit https://doi.org/10.1111/apt.15188 and…”
    Get full text
    Journal Article
  2. 2
  3. 3

    The safety of stopping nucleos(t)ide analogue treatment in patients with HBeAg‐negative chronic hepatitis B by Wong, Grace L.‐H., Chan, Henry L.‐Y., Yuen, Becky W.‐Y., Tse, Yee‐Kit, Luk, Hester W.‐S., Yip, Terry C.‐F., Hui, Vicki W.‐K., Liang, Lilian Y., Lee, Hye‐Won, Lui, Grace C.‐Y., Wong, Vincent W.‐S.

    Published in Liver international (01-03-2020)
    “…Background The rates of hepatitis B surface antigen (HBsAg) seroclearance after stopping nucleos(t)ide analogues (NA) in European (19% in 2 years) and Asian…”
    Get full text
    Journal Article
  4. 4

    Association of genetic variations with NAFLD in lean individuals by Lin, Huapeng, Wong, Grace L.‐H., Whatling, Carl, Chan, Anthony W.‐H., Leung, Howard H.‐W., Tse, Chi‐Hang, Shu, Sally S.‐T., Chim, Angel M.‐L., Lai, Jimmy C.‐T., Yip, Terry C.‐F., Wong, Vincent W.‐S.

    Published in Liver international (01-01-2022)
    “…Background & Aims How adiposity influences the effect of genetic variants on non‐alcoholic fatty liver disease (NAFLD) in the Asian population remains unclear…”
    Get full text
    Journal Article
  5. 5

    Glucose-lowering drugs and outcome from COVID-19 among patients with type 2 diabetes mellitus: a population-wide analysis in Hong Kong by Luk, Andrea On Yan, Yip, Terry C F, Zhang, Xinge, Kong, Alice Pik Shan, Wong, Vincent Wai-Sun, Ma, Ronald Ching Wan, Wong, Grace Lai-Hung

    Published in BMJ open (20-10-2021)
    “…ObjectivesTo investigate the association between baseline use of glucose-lowering drugs and serious clinical outcome among patients with type 2…”
    Get full text
    Journal Article
  6. 6
  7. 7

    Diagnostic and prognostic performance of the SAFE score in non‐alcoholic fatty liver disease by Li, Guanlin, Lin, Huapeng, Sripongpun, Pimsiri, Liang, Lilian Y., Zhang, Xinrong, Wong, Vincent W.S., Wong, Grace L.H., Kim, W. Ray, Yip, Terry C.F.

    Published in Liver international (01-01-2024)
    “…Background & Aims The steatosis‐associated fibrosis estimator (SAFE) score was developed to detect clinically significant liver fibrosis in patients with NAFLD…”
    Get full text
    Journal Article
  8. 8
  9. 9

    Thromboembolic Risks with Concurrent Direct Oral Anticoagulants and Antiseizure Medications: A Population-Based Analysis by Ip, Bonaventure Y., Ko, Ho, Wong, Grace LH, Yip, Terry CF, Lau, Louis HS, Lau, Alexander YL, Leng, Xinyi, Leung, Howan, Chan, Howard HW, Chan, Helen YF, Mok, Vincent CT, Soo, Yannie OY, Leung, Thomas W.

    Published in CNS drugs (01-12-2022)
    “…Background and Objective Drug–drug interactions between direct oral anticoagulants (DOAC) and antiseizure medications via the cytochrome P450 (CYP) or the…”
    Get full text
    Journal Article
  10. 10
  11. 11
  12. 12
  13. 13
  14. 14
  15. 15
  16. 16
  17. 17
  18. 18
  19. 19
  20. 20

    Risks of post-colonoscopic polypectomy bleeding and thromboembolism with warfarin and direct oral anticoagulants: a population-based analysis by Lau, Louis Hs, Guo, Cosmos Lt, Yip, Terry Cf, Mak, Joyce Wy, Wong, Sunny H, Lam, Kelvin Ly, Wong, Grace Lh, Ng, Siew C, Chan, Francis Kl

    Published in Gut (01-01-2022)
    “…There were limited data on the risk of post-polypectomy bleeding (PPB) in patients on direct oral anticoagulants (DOAC). We aimed to evaluate the PPB and…”
    Get more information
    Journal Article